Latest Articles
New treatment offers hope for women with advanced womb cancer - Irish Star
New treatment offers hope for women with advanced womb cancer Irish Star
Published: Aug. 7, 2025, noon
NICE backs KEYTRUDA combination for advanced endometrial cancer - PharmaTimes
NICE backs KEYTRUDA combination for advanced endometrial cancer PharmaTimes
Published: Aug. 7, 2025, 9:15 a.m.
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis - Frontiers
Toxicity and Efficacy of Lenvatinib Plus Pembrolizumab in Advanced Endometrial Cancer: A Real-World Retrospective Analysis Frontiers
Published: Aug. 7, 2025, 7:56 a.m.
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers - APN News
Apollo Cancer Centres Launches ‘End-O Check’ – An Early Detection and Diagnosis Program for Endometrial and Ovarian Cancers APN News
Published: Aug. 7, 2025, 5:45 a.m.
Treatment for advanced womb cancer ‘major step forward’ - MSN
Treatment for advanced womb cancer ‘major step forward’ MSN
Published: Aug. 7, 2025, 12:44 a.m.
Anti-cancer Drugs in Endometriosis Management: Mechanisms and Therapeutic Potential.
Endometriosis is a widespread estrogen-driven condition causing pelvic pain and infertility in women. This disease shares five features with cancer: Intrinsic growth signals, insensitivity to antiproliferative signals, impaired apoptosis, induction …
Published: Aug. 7, 2025, midnight
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers - The ASCO Post
Nivolumab Plus Ipilimumab in Advanced Ovarian and Endometrial Clear Cell Cancers The ASCO Post
Published: Aug. 6, 2025, 3:38 p.m.
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database - Frontiers
Real-World Study on Adverse Drug Reactions of Pembrolizumab in Endometrial Cancer Treatment: Insights from the FAERS Database Frontiers
Published: Aug. 6, 2025, 2:27 p.m.
NICE approves first immunotherapy combination for endometrial cancer - Wired Gov
NICE approves first immunotherapy combination for endometrial cancer Wired Gov
Published: Aug. 6, 2025, 1:13 p.m.
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials - Stock Titan
Breakthrough: New Cancer Drug Ampligen Delivers Promising Results in Pancreatic, Ovarian, and Breast Cancer Trials Stock Titan
Published: Aug. 6, 2025, 1 p.m.
Link copied to clipboard!